DE69232911D1 - Verwendung eines polyhydroxybenzamids oder dessen Derivat zur Herstellung eines Medikaments für die Behandlung von viralen Infektionen - Google Patents

Verwendung eines polyhydroxybenzamids oder dessen Derivat zur Herstellung eines Medikaments für die Behandlung von viralen Infektionen

Info

Publication number
DE69232911D1
DE69232911D1 DE69232911T DE69232911T DE69232911D1 DE 69232911 D1 DE69232911 D1 DE 69232911D1 DE 69232911 T DE69232911 T DE 69232911T DE 69232911 T DE69232911 T DE 69232911T DE 69232911 D1 DE69232911 D1 DE 69232911D1
Authority
DE
Germany
Prior art keywords
polyhydroxybenzamide
medicament
derivative
manufacture
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69232911T
Other languages
English (en)
Other versions
DE69232911T2 (de
Inventor
Howard L Elford
Riet Bartholomeus Van T
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MOLECULES FOR HEALTH, INC., RICHMOND, VA., US
Original Assignee
Howard L Elford
Riet Bartholomeus Van T
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Howard L Elford, Riet Bartholomeus Van T filed Critical Howard L Elford
Application granted granted Critical
Publication of DE69232911D1 publication Critical patent/DE69232911D1/de
Publication of DE69232911T2 publication Critical patent/DE69232911T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69232911T 1991-10-31 1992-10-29 Verwendung eines polyhydroxybenzamids oder dessen Derivat zur Herstellung eines Medikaments für die Behandlung von viralen Infektionen Expired - Lifetime DE69232911T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78598291A 1991-10-31 1991-10-31
PCT/US1992/009377 WO1993012782A1 (en) 1991-10-31 1992-10-29 Method of treating viral diseases

Publications (2)

Publication Number Publication Date
DE69232911D1 true DE69232911D1 (de) 2003-03-06
DE69232911T2 DE69232911T2 (de) 2003-11-13

Family

ID=25137227

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69232911T Expired - Lifetime DE69232911T2 (de) 1991-10-31 1992-10-29 Verwendung eines polyhydroxybenzamids oder dessen Derivat zur Herstellung eines Medikaments für die Behandlung von viralen Infektionen

Country Status (5)

Country Link
US (1) US6248782B1 (de)
EP (1) EP0610444B1 (de)
DE (1) DE69232911T2 (de)
ES (1) ES2191662T3 (de)
WO (1) WO1993012782A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69433953T2 (de) * 1993-05-21 2005-08-25 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Neues Verfahen zur Hemmung der Replikation der virusabhängigen reversen Transkriptase durch Verwendung von Didesoxynukleotid-Synthese Inhibitoren
US6093702A (en) * 1993-12-20 2000-07-25 The United States Of America As Represented By The Department Of Health And Human Services Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread
US6028111A (en) * 1996-03-08 2000-02-22 Oxigene, Inc. Compositions and use of benzamides and nicotinamides as anti-inflammatory agents
US6713517B1 (en) 1996-03-08 2004-03-30 Oxigene, Inc. Use of aryl N-substituted carboxamides directly and as radio-and chemosensitizers for killing tumor and cancer cells and novel compounds for such use
WO2002085358A2 (en) * 2001-04-20 2002-10-31 Vion Pharmaceuticals, Inc. Antiviral agents and methods of treating viral infections
WO2005115405A1 (en) * 2004-04-28 2005-12-08 Molecules For Health, Inc. Methods for treating or preventing restenosis and other vascular proliferative disorders
EP2030615A3 (de) 2007-08-13 2009-12-02 ELFORD, Howard L. Ribonukleotidreduktase-Inhibitoren zur Verwendung für die Behandlung oder Vorbeugung von Nervenentzündung- oder Autoimmunerkrankungen
WO2011084619A2 (en) * 2009-12-16 2011-07-14 Mark Stahl Elimination of pathogenic infection in farmed animal populations
MD4132C1 (ro) * 2010-12-13 2012-05-31 Государственный Университет Молд0 Di(µ-S)-bis{cloro-[fenil(piridin-2-il)metanon-tiosemicarbazonato(1-)]cupru} care manifestă proprietatea de inhibare a proliferării celulelor T-47D ale cancerului mamar
CN104434890A (zh) * 2013-09-24 2015-03-25 上海市计划生育科学研究所 扁桃酸的用途
US20220274929A1 (en) * 2019-02-25 2022-09-01 The Regents Of The University Of California Thiosemicarbazone compounds and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US647940A (en) * 1899-02-01 1900-04-24 Gen Electric System of train control.
US1715251A (en) * 1924-12-24 1929-05-28 Sabalitschka Theodor Disinfecting
US2952583A (en) * 1958-11-05 1960-09-13 Dow Chemical Co Composition and method for controlling plant viruses
SU393031A1 (ru) 1972-01-03 1973-08-10 Металлический стержень для литейных форм
US4623659A (en) * 1983-05-23 1986-11-18 Riet Bartholomeus Van T Polyhydroxybenzoic acid derivatives
FR2550785B1 (fr) * 1983-08-18 1985-12-06 Sanofi Sa Nouvelles compositions a activite antimicrobienne contenant des derives de l'acide benzoique, leur procede de preparation, leur utilisation en tant que medicaments desinfectants ou conservateurs
JPS62149666A (ja) 1985-12-25 1987-07-03 Shionogi & Co Ltd Ｎ−ビニルアゾ−ル類
DE3715281A1 (de) * 1987-05-05 1988-11-24 Kroeger Hans Neue antiviral wirksame substanz
US5110799A (en) * 1989-07-28 1992-05-05 Merck & Co., Inc. Antiherpetic agents
DE69433953T2 (de) 1993-05-21 2005-08-25 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Neues Verfahen zur Hemmung der Replikation der virusabhängigen reversen Transkriptase durch Verwendung von Didesoxynukleotid-Synthese Inhibitoren
US6093702A (en) 1993-12-20 2000-07-25 The United States Of America As Represented By The Department Of Health And Human Services Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread
US5521161A (en) 1993-12-20 1996-05-28 Compagnie De Developpment Aguettant S.A. Method of treating HIV in humans by administration of ddI and hydroxycarbamide

Also Published As

Publication number Publication date
EP0610444A4 (de) 1995-05-17
DE69232911T2 (de) 2003-11-13
ES2191662T3 (es) 2003-09-16
EP0610444B1 (de) 2003-01-29
US6248782B1 (en) 2001-06-19
EP0610444A1 (de) 1994-08-17
WO1993012782A1 (en) 1993-07-08

Similar Documents

Publication Publication Date Title
DE122005000002I1 (de) Verwendung von Venlafaxin oder eines Aryloxy-Propanaminderivates zur Herstellung eines Medikaments zur Behandlung von Inkontinenz.
DE3855525T2 (de) Verwendung eines Protein gebundenen Polysaccharid Zur Herstellung eines Arzneimittels für die Behandlung von AIDS.
DE69117419D1 (de) Silikongummilaminat und Verfahren zu seiner Herstellung
DE69103230T2 (de) 1-Pyridylimidazolderivat und Verfahren zur Herstellung und Anwendung.
DE69113386T2 (de) Herstellung von Medikamenten zur Behandlung von Asthma, unter Verwendung von (S)-Alpha-Fluoromethyl-Histidin und dessen Estern.
DE69232911T2 (de) Verwendung eines polyhydroxybenzamids oder dessen Derivat zur Herstellung eines Medikaments für die Behandlung von viralen Infektionen
DE69233725D1 (de) Verwendung von DNA oder RNA zur Herstellung eines Medikaments zur Behandlung von Tumoren
DE69637449D1 (de) Verwendung von alpha-hydroxysäuren zur herstellung eines arzneimittels für die behandlung von entzündungen
DE69635298D1 (de) Verwendung von Acetylsalicylsäuren zur Herstellung eines Medikaments für die Behandlung von Hautverletzungen
DE69207696T2 (de) Einschritt-Verfahren zur Herstellung von Dirithromycin
DE69423577D1 (de) Verwendung von Oenothein B zur Herstellung eines Medikaments zur Behandlung der durch Hyperandrogenität bedingte Störungen.
DE69105823T2 (de) Verfahren zur Behandlung von Metallmatrixverbundwerkstoffen.
DE68905657D1 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
DE69300037D1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
DE69610045D1 (de) Verwendung eines Rohpflanzenextraktes zur Herstellung eines Arzneimittels zur Behandlung von HIV-Infektionen
DE69620786D1 (de) Verwendung von cholinesterase-inhibitoren für die herstellung eines medikaments zur behandlung von xerostomie
DE69115758D1 (de) Verfahren zur Herstellung von 3,5-Difluoranilin und dessen Derivat
DE69208385T2 (de) Verfahren zur Herstellung von N-Alkyl-N-Methylamin oder N-Alkenyl-N-Methylamin
DE69632117D1 (de) Verwendung von 8,9-Dehydroestron zur Herstellung eines Arzneimittels zur Behandlung von durch freie Radikale verursachte Krankheiten
DE69202842T2 (de) Verbessertes Herzstück und Verfahren zur dessen Herstellung.
DE69215754T2 (de) Verfahren zur Herstellung von Alpha-L-Aspartyl-L-Phenylalanin-methylester oder dessen Hydrochlorid
DE69313420D1 (de) Verfahren zur Herstellung von 4-Nitrosodiphenylamin oder dessen Salzen
DE69211959T2 (de) Plattenstruktur und Verfahren zur dessen Herstellung
DE59209807D1 (de) Verfahren zur Herstellung eines biologisch aktiven menschlichen Blutserums
DE69223811D1 (de) Verwendung eines homöopathisches Erzeugnisses zur Herstellung eines Arzneimittels für die Behandlung von metabolischen Krankheiten

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: MOLECULES FOR HEALTH, INC., RICHMOND, VA., US

8381 Inventor (new situation)

Inventor name: INVENTOR IS APPLICANT

8364 No opposition during term of opposition